What is the Rossari Biotech Ltd share price today?

The share price of NSE:ROSSARI-EQ on 01 Oct 2026 (as of 15:04:44 IST) is ₹421.9.

What is the NSE:ROSSARI-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:ROSSARI-EQ 52 week high low range shows a high of ₹690.3 and a low of ₹375.

What is the Rossari Biotech Ltd market cap?

As on 01 Oct 2026, Rossari Biotech Ltd market cap is ₹23107700000.

What is the shareholding pattern of Rossari Biotech Ltd Stock?

The shareholding pattern of Rossari Biotech Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 68.14% Foreign Institutional Investors (FII): 2.03% Domestic Institutional Investors (DII): 4.87% Mutual Funds: 9.77% Retail & Others: 15.19% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Rossari Biotech Ltd?

The Price-to-Earnings (PE) ratio of Rossari Biotech Ltd is 15.3323, and the Price-to-Book (PB) ratio is 1.5779, as on 01 Oct 2026.

Rossari Biotech Share Price

433.30+6.60 (+1.55%)

-33.41% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+1.55%

1 Week

+5.73%

1 Month

-2.88%

3 Month

-19.99%

6 Month

-14.07%

YTD

-25.57%

1 Year

-33.41%

5 Year

-72.42%

10 Year

Max

-35.26%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

422.00

404.10

375.00

High

441.25

474.20

544.55

575.00

690.30

About

Rossari Biotech Limited is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, Read more

Chemicals

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SOLARINDSNSE

PIDILITINDNSE

SRFNSE

FLUOROCHEMNSE

NAVINFLUORNSE

GODREJINDNSE

AETHERNSE

DEEPAKNTRNSE

AARTIINDNSE

ATULNSE

ROSSARINSE

LTP

1W Low

1W High

Market cap (₹)

20170+170 (0.85%)

19925

20398

1,81,930Cr

1499.5+17.5 (1.18%)

1462

1506.20

1,52,271Cr

2499.7-19.8 (-0.79%)

2452.50

2535.80

73,810Cr

4632.1+155.3 (3.47%)

4485

4680

49,998Cr

8457+104.5 (1.25%)

8330.50

8605

43,440Cr

1004+18.6 (1.89%)

980.40

1012.90

33,630Cr

1682.5-65.6 (-3.75%)

1659.10

1810

22,785Cr

1645.4+23.5 (1.45%)

1597.20

1662.50

22,109Cr

497.9+37.75 (8.20%)

460.45

499.90

17,680Cr

5972+89.5 (1.52%)

5891

6074.50

17,655Cr

432+22.2 (5.42%)

404.10

441.25

2,372Cr

Rossari Biotech Share Price

433.30+6.60 (+1.55%)

-33.41% past 1 Year

Financial overview

Compounded Sales Growth

10 years30%

5 years28%

3 years13%

Last year15%

Compounded Profit Growth

10 years46%

5 years13%

3 years12%

Last year9%

Stock Price CAGR

10 years-

5 years-23%

3 years-19%

1 year-34%

Return on Equity

10 years23%

5 years13%

3 years12%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
30%	28%	13%	15%
46%	13%	12%	9%
-	-23%	-19%	-34%
23%	13%	12%	12%

Peer Comparison

Symbol

SOLARINDS

PIDILITIND

SRF

FLUOROCHEM

NAVINFLUOR

GODREJIND

AETHER

DEEPAKNTR

AARTIIND

ATUL

ROSSARI

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
20,170	₹181930 Cr	91.36	72.11	250.42	₹1678 Cr
1,499.5	₹152271 Cr	57.48	8.57	29.89	₹2449 Cr
2,499.7	₹73810 Cr	34.14	25.6	102.33	₹1835 Cr
4,632.1	₹49998 Cr	81.3	20.09	90.49	₹577 Cr
8,457	₹43440 Cr	55.01	47.43	184.25	₹664 Cr
1,004	₹33630 Cr	28.6	8.44	50.37	₹1241 Cr
1,682.5	₹22785 Cr	96.88	4.73	23.27	₹219 Cr
1,645.4	₹22109 Cr	28.23	25.29	74.81	₹551 Cr
497.9	₹17680 Cr	33.3	4.28	27.98	₹419 Cr
5,972	₹17655 Cr	22.2	83.32	378.24	₹678 Cr
432	₹2372 Cr	15.74	6.34	42.91	₹149 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019
₹697 Cr	₹685 Cr	₹582 Cr	₹586 Cr	₹544 Cr	₹580 Cr	₹513 Cr	₹498 Cr	₹490 Cr	₹473 Cr	₹464 Cr	₹483 Cr	₹411 Cr	₹406 Cr	₹389 Cr	₹425 Cr	₹435 Cr	₹439 Cr	₹428 Cr	₹385 Cr	₹231 Cr	₹218 Cr	₹210 Cr	₹172 Cr	₹109 Cr	₹160 Cr	₹162 Cr	₹150 Cr	₹128 Cr
₹3 Cr	₹19 Cr	₹51 L	₹2 Cr	₹1 Cr	₹2 Cr	₹55 L	₹72 L	₹95 L	₹39 L	₹4 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹82 L	₹74 L	₹2 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹76 L	₹4 Cr	₹2 Cr	₹2 Cr	₹6 L	₹84 L	₹78 L
₹700 Cr	₹704 Cr	₹582 Cr	₹588 Cr	₹545 Cr	₹581 Cr	₹513 Cr	₹499 Cr	₹491 Cr	₹473 Cr	₹467 Cr	₹485 Cr	₹413 Cr	₹409 Cr	₹390 Cr	₹426 Cr	₹435 Cr	₹441 Cr	₹434 Cr	₹388 Cr	₹234 Cr	₹221 Cr	₹211 Cr	₹176 Cr	₹111 Cr	₹162 Cr	₹162 Cr	₹151 Cr	₹129 Cr
₹642 Cr	₹631 Cr	₹532 Cr	₹532 Cr	₹494 Cr	₹528 Cr	₹466 Cr	₹448 Cr	₹440 Cr	₹425 Cr	₹415 Cr	₹435 Cr	₹367 Cr	₹368 Cr	₹351 Cr	₹385 Cr	₹392 Cr	₹403 Cr	₹398 Cr	₹351 Cr	₹200 Cr	₹190 Cr	₹182 Cr	₹147 Cr	₹90 Cr	₹140 Cr	₹137 Cr	₹126 Cr	₹109 Cr
₹84 Cr	₹96 Cr	₹69 Cr	₹74 Cr	₹69 Cr	₹71 Cr	₹65 Cr	₹67 Cr	₹66 Cr	₹64 Cr	₹67 Cr	₹65 Cr	₹60 Cr	₹57 Cr	₹55 Cr	₹57 Cr	₹58 Cr	₹54 Cr	₹53 Cr	₹48 Cr	₹40 Cr	₹38 Cr	₹35 Cr	₹34 Cr	₹25 Cr	₹26 Cr	₹30 Cr	₹29 Cr	₹23 Cr
₹11 Cr	₹9 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹8 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹63 L	₹80 L	₹36 L	₹69 L	₹1 Cr	₹1 Cr	₹87 L	₹1 Cr	₹46 L
₹47 Cr	₹64 Cr	₹42 Cr	₹49 Cr	₹46 Cr	₹48 Cr	₹42 Cr	₹48 Cr	₹47 Cr	₹45 Cr	₹48 Cr	₹45 Cr	₹40 Cr	₹37 Cr	₹35 Cr	₹34 Cr	₹38 Cr	₹33 Cr	₹32 Cr	₹36 Cr	₹33 Cr	₹30 Cr	₹28 Cr	₹28 Cr	₹20 Cr	₹20 Cr	₹25 Cr	₹24 Cr	₹19 Cr
₹35 Cr	₹45 Cr	₹32 Cr	₹36 Cr	₹33 Cr	₹34 Cr	₹31 Cr	₹35 Cr	₹35 Cr	₹34 Cr	₹34 Cr	₹33 Cr	₹29 Cr	₹29 Cr	₹26 Cr	₹24 Cr	₹28 Cr	₹23 Cr	₹22 Cr	₹26 Cr	₹25 Cr	₹22 Cr	₹22 Cr	₹21 Cr	₹15 Cr	₹15 Cr	₹18 Cr	₹18 Cr	₹14 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
—	—	—	—	—	—	—	—	—	—	—	—	—
₹11 Cr	₹11 Cr	₹11 Cr	₹11 Cr	₹11 Cr	₹10 Cr	₹10 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr
₹5 Cr	₹2 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹49 L	₹0	₹0	₹0	₹0	₹0	₹4 Cr
₹1317 Cr	₹1172 Cr	₹1033 Cr	₹901 Cr	₹791 Cr	₹396 Cr	₹276 Cr	₹119 Cr	₹90 Cr	₹61 Cr	₹46 Cr	₹42 Cr	₹40 Cr
₹1317 Cr	₹1172 Cr	₹1033 Cr	₹901 Cr	₹791 Cr	₹396 Cr	₹276 Cr	₹119 Cr	₹90 Cr	₹61 Cr	₹46 Cr	₹42 Cr	₹40 Cr
₹1333 Cr	₹1185 Cr	₹1048 Cr	₹915 Cr	₹805 Cr	₹409 Cr	₹287 Cr	₹124 Cr	₹94 Cr	₹65 Cr	₹50 Cr	₹47 Cr	₹48 Cr
₹94 Cr	₹100 Cr	₹33 Cr	₹35 Cr	₹0	₹0	₹34 Cr	₹67 L	₹1 Cr	₹2 Cr	₹7 Cr	₹9 Cr	₹7 Cr
₹28 Cr	₹36 Cr	₹47 Cr	₹56 Cr	₹68 Cr	₹98 L	₹49 L	₹2 Cr	-₹71 L	-₹40 L	-₹25 L	₹4 L	₹44 L
₹20 Cr	₹22 Cr	₹11 Cr	₹8 Cr	₹85 Cr	₹0	₹0	₹0	₹3 Cr	₹0	₹0	₹0	₹0
₹172 Cr	₹103 Cr	₹102 Cr	₹82 Cr	₹99 Cr	₹58 Cr	₹35 Cr	₹35 Cr	₹0	₹0	₹0	₹0	₹0
₹315 Cr	₹262 Cr	₹193 Cr	₹181 Cr	₹251 Cr	₹59 Cr	₹69 Cr	₹37 Cr	₹4 Cr	₹2 Cr	₹7 Cr	₹9 Cr	₹8 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹323 Cr	₹286 Cr	₹219 Cr	₹181 Cr	₹186 Cr	₹131 Cr	₹97 Cr	₹106 Cr	₹40 Cr	₹32 Cr	₹28 Cr	₹18 Cr	₹28 Cr
₹165 Cr	₹155 Cr	₹128 Cr	₹126 Cr	₹100 Cr	₹17 Cr	₹20 Cr	₹12 Cr	₹6 Cr	₹4 Cr	₹7 Cr	₹8 Cr	₹11 Cr
₹284 Cr	₹75 Cr	₹63 Cr	₹29 Cr	₹0	₹0	₹27 Cr	₹3 Cr	₹19 Cr	₹20 Cr	₹15 Cr	₹30 Cr	₹29 Cr
₹234 Cr	₹223 Cr	₹174 Cr	₹140 Cr	₹74 Cr	₹28 Cr	₹24 Cr	₹63 L	₹3 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹1 Cr
₹1007 Cr	₹740 Cr	₹584 Cr	₹476 Cr	₹360 Cr	₹177 Cr	₹169 Cr	₹122 Cr	₹68 Cr	₹57 Cr	₹52 Cr	₹58 Cr	₹70 Cr
₹2655 Cr	₹2187 Cr	₹1825 Cr	₹1572 Cr	₹1417 Cr	₹645 Cr	₹525 Cr	₹283 Cr	₹166 Cr	₹124 Cr	₹109 Cr	₹114 Cr	₹125 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹11 L	₹22 L	₹31 L	₹29 L
₹408 Cr	₹188 Cr	₹106 Cr	₹74 Cr	₹8 Cr	₹0	₹67 Cr	₹5 Cr	₹21 Cr	₹22 Cr	₹22 Cr	₹44 Cr	₹44 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹1133 Cr	₹878 Cr	₹791 Cr	₹743 Cr	₹704 Cr	₹234 Cr	₹122 Cr	₹86 Cr	₹88 Cr	₹76 Cr	₹38 Cr	₹67 Cr	₹67 Cr
₹349 Cr	₹279 Cr	₹213 Cr	₹158 Cr	₹97 Cr	₹53 Cr	₹29 Cr	₹12 Cr	₹43 Cr	₹38 Cr	₹0	₹30 Cr	₹25 Cr
₹784 Cr	₹598 Cr	₹578 Cr	₹585 Cr	₹607 Cr	₹181 Cr	₹94 Cr	₹74 Cr	₹45 Cr	₹38 Cr	₹38 Cr	₹38 Cr	₹42 Cr
₹173 Cr	₹140 Cr	₹47 Cr	₹13 Cr	₹1 Cr	₹32 L	₹22 Cr	₹3 Cr	₹10 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹7 Cr
₹27 Cr	₹26 Cr	₹25 Cr	₹25 Cr	₹24 Cr	₹0	₹4 Cr	₹0	₹3 Cr	₹25,400	₹25,400	₹25,400	₹25,400
₹27 Cr	₹26 Cr	₹25 Cr	₹25 Cr	₹24 Cr	₹0	₹4 Cr	₹0	₹3 Cr	₹25,400	₹25,400	₹25,400	₹25,400
₹206 Cr	₹175 Cr	₹171 Cr	₹96 Cr	₹109 Cr	₹62 Cr	₹58 Cr	₹39 Cr	₹2 Cr	₹80 L	₹65 L	₹59 L	₹53 L
₹3 Cr	₹11 L	₹7 L	₹12 L	₹36 L	₹20 Cr	₹42 L	₹7 Cr	₹0	₹0	₹0	₹0	₹0
₹1194 Cr	₹940 Cr	₹821 Cr	₹723 Cr	₹742 Cr	₹263 Cr	₹178 Cr	₹123 Cr	₹60 Cr	₹47 Cr	₹46 Cr	₹46 Cr	₹50 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹35 Cr	₹57 Cr	₹38 Cr	₹26 Cr	₹12 Cr	₹0	₹14 Cr	₹0	₹4 Cr	₹0	₹0	₹0	₹0
₹405 Cr	₹355 Cr	₹282 Cr	₹188 Cr	₹190 Cr	₹95 Cr	₹58 Cr	₹55 Cr	₹35 Cr	₹24 Cr	₹25 Cr	₹31 Cr	₹42 Cr
₹557 Cr	₹475 Cr	₹425 Cr	₹354 Cr	₹305 Cr	₹144 Cr	₹94 Cr	₹86 Cr	₹60 Cr	₹47 Cr	₹31 Cr	₹30 Cr	₹28 Cr
₹92 Cr	₹57 Cr	₹30 Cr	₹124 Cr	₹52 Cr	₹88 Cr	₹127 Cr	₹6 Cr	₹76 L	₹2 Cr	₹3 Cr	₹1 Cr	₹99 L
₹5 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹6 Cr	₹2 Cr	₹5 Cr	₹89 L	₹32 L	₹10 L	₹12 L	₹14 L	₹17 L
₹359 Cr	₹299 Cr	₹225 Cr	₹152 Cr	₹111 Cr	₹52 Cr	₹48 Cr	₹12 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹6 Cr	₹5 Cr
₹1453 Cr	₹1246 Cr	₹1003 Cr	₹847 Cr	₹675 Cr	₹381 Cr	₹346 Cr	₹160 Cr	₹106 Cr	₹77 Cr	₹63 Cr	₹69 Cr	₹76 Cr
₹446 Cr	₹505 Cr	₹419 Cr	₹372 Cr	₹315 Cr	₹205 Cr	₹178 Cr	₹38 Cr	₹38 Cr	₹20 Cr	₹11 Cr	₹10 Cr	₹6 Cr
₹2655 Cr	₹2187 Cr	₹1825 Cr	₹1572 Cr	₹1417 Cr	₹645 Cr	₹525 Cr	₹283 Cr	₹166 Cr	₹124 Cr	₹109 Cr	₹114 Cr	₹125 Cr
₹240	₹214	₹189	₹165	₹146	₹78	₹56	₹281	₹214	₹149	₹114	₹107	₹101
₹240	₹214	₹189	₹165	₹146	₹78	₹56	₹26	₹19	₹14	₹10	₹10	₹9

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
₹203 Cr	₹185 Cr	₹178 Cr	₹144 Cr	₹136 Cr	₹107 Cr	₹88 Cr	₹63 Cr	₹40 Cr	₹19 Cr	₹5 Cr	₹5 Cr	₹4 Cr
₹85 Cr	₹84 Cr	₹76 Cr	₹83 Cr	₹55 Cr	₹21 Cr	₹20 Cr	₹17 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹9 Cr	₹10 Cr
-₹154 Cr	-₹73 Cr	-₹157 Cr	-₹28 Cr	-₹112 Cr	-₹48 Cr	-₹31 Cr	₹11 Cr	-₹11 Cr	-₹14 Cr	₹13 Cr	-₹5 Cr	₹1 Cr
₹134 Cr	₹197 Cr	₹97 Cr	₹199 Cr	₹79 Cr	₹79 Cr	₹77 Cr	₹92 Cr	₹34 Cr	₹10 Cr	₹25 Cr	₹9 Cr	₹16 Cr
₹65 Cr	₹137 Cr	₹43 Cr	₹152 Cr	₹29 Cr	₹48 Cr	₹57 Cr	₹71 Cr	₹24 Cr	₹7 Cr	₹26 Cr	₹8 Cr	₹15 Cr
-₹219 Cr	-₹184 Cr	-₹103 Cr	-₹181 Cr	-₹299 Cr	-₹37 Cr	-₹190 Cr	-₹36 Cr	-₹20 Cr	-₹6 Cr	-₹5 Cr	-₹2 Cr	-₹4 Cr
₹186 Cr	₹65 Cr	₹16 Cr	₹61 Cr	₹292 Cr	-₹25 Cr	₹157 Cr	-₹29 Cr	-₹5 Cr	-₹2 Cr	-₹19 Cr	-₹6 Cr	-₹11 Cr
₹32 Cr	₹19 Cr	-₹44 Cr	₹32 Cr	₹22 Cr	-₹14 Cr	₹23 Cr	₹6 Cr	-₹2 Cr	-₹35 L	₹2 Cr	₹4 L	₹37 L
₹44 Cr	₹25 Cr	₹69 Cr	₹37 Cr	₹15 Cr	₹29 Cr	₹6 Cr	₹63 L	₹2 Cr	₹3 Cr	₹1 Cr	₹99 L	₹62 L
-₹80 L	₹38 L	-₹25 L	₹20 L	₹0	₹10,000	-₹20,000	-₹49 L	₹0	₹0	₹0	₹0	₹0
₹75 Cr	₹44 Cr	₹25 Cr	₹69 Cr	₹37 Cr	₹15 Cr	₹29 Cr	₹6 Cr	₹76 L	₹2 Cr	₹3 Cr	₹1 Cr	₹99 L

Fundamental Ratios

Consolidated

Standalone

No results found

Rossari Biotech Share Price

433.30+6.60 (+1.55%)

-33.41% past 1 Year

Shareholding summary

Promoters

68.14%

FII

2.03%

DII

4.87%

9.77%

Others

15.19%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
68.14%	68.15%	68.16%	68.17%	68.17%	68.18%
2.03%	2.18%	2.32%	2.70%	3.48%	3.98%
4.87%	4.83%	4.78%	4.91%	4.42%	4.30%
9.77%	13.38%	13.47%	13.27%	13.42%	13.29%
15.19%	11.46%	11.27%	10.95%	10.51%	10.25%

Bulk & block deals

Name

Bhupesh Kumar Lodha

Goldman Sachs Funds Goldman Sachs India Equity Portfolio

Goldman Sachs India Fund Limited

Public Sector Pension Investment Board

Iifl Special Opportunities Fund Series 4

Plutus Wealth Management Llp

Two Roads Trading Private Limited

Vaibhav Stock And Derivatives Broking Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
30 Apr 2026	Purchase	14.65 Cr	₹491.50	2.98 L	Bulk	0.537963	NSE
20 Sep 2021	Purchase	98.50 Cr	₹1,478.65	6.66 L	Block	1.202538	BSE
20 Sep 2021	Sell	98.50 Cr	₹1,478.65	6.66 L	Block	1.202538	BSE
19 Jul 2021	Purchase	20.85 Cr	₹1,249.50	1.67 L	Block	0.30125	NSE
19 Jul 2021	Sell	20.85 Cr	₹1,249.50	1.67 L	Block	0.30125	NSE
02 Sep 2020	Purchase	23.21 Cr	₹773.82	3 L	Bulk	0.541574	NSE
27 Jul 2020	Purchase	20.12 Cr	₹717.68	2.80 L	Bulk	0.506191	NSE
27 Jul 2020	Sell	20.13 Cr	₹718.07	2.80 L	Bulk	0.506191	NSE
24 Jul 2020	Purchase	23.31 Cr	₹758.13	3.07 L	Bulk	0.555106	NSE
24 Jul 2020	Sell	23.32 Cr	₹758.44	3.07 L	Bulk	0.555106	NSE

Insider trading & SAST

Client name

Sbi Mutual Fund

Yash Sunil Chari

Yash Sunil Chari & Other

Chari Family Trust

Sunil Srinivasan Chari

Jyotishna Sunil Chari

Yash Sunil Chari & Others

Sunil Srinivasan Chari

Jyotishna Sunil Chari

Chari Family Trust - In The Name Of Sunil Srinivasan Chari & Jyotishna Sunil Chari

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
26 May 2026	—	Disposal	0.28	2.97	0	—	1.57 L	17 Apr 2026	Market	16,48,093	SAST	29(2)	—
13 Oct 2025	Promoter	Acquisition	4.15	4.45	0	—	23 L	28 Aug 2025	Off Market / Inter se transfer	24,65,000	SAST	29(2)	—
13 Oct 2025	Other	Acquisition	15.62	—	0	—	88 L	28 Aug 2025	-	—	SAST	10(6)	—
13 Oct 2025	Promoter	Acquisition	9.03	9.23	0	—	50 L	28 Aug 2025	Off Market / Inter se transfer	51,10,000	SAST	29(2)	—
13 Oct 2025	Promoter	Disposal	15.89	13.17	0	—	88 L	28 Aug 2025	Off Market / Inter se transfer	72,89,320	SAST	29(2)	—
13 Oct 2025	Promoter	Acquisition	2.71	4.52	0	—	15 L	28 Aug 2025	Off Market / Inter se transfer	25,00,330	SAST	29(2)	—
18 Sep 2025	Other	Acquisition	15.89	—	0	—	88 L	28 Aug 2025	—	—	SAST	10(5)	—
29 Aug 2025	Promoter	Disposal	15.893944	13.17	543.18 Cr	₹617.25	88 L	28 Aug 2025	Gift	72,89,320	Insider Trading	—	Equity Shares
29 Aug 2025	Promoter Group	Acquisition	2.709195	4.52	92.59 Cr	₹617.25	15 L	28 Aug 2025	Gift	25,00,330	Insider Trading	—	Equity Shares
29 Aug 2025	Promoter Group	Acquisition	9.03065	9.23	308.62 Cr	₹617.25	50 L	28 Aug 2025	Gift	51,10,000	Insider Trading	—	Equity Shares

Rossari Biotech Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Rossari Biotech Share Price

Rossari Biotech Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Rossari Biotech Share Price

Rossari Biotech Share Price

Oscillators

Moving averages

Rossari Biotech Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Rossari Biotech Share Price

Corporate Actions

Company details

Rossari Biotech Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Rossari Biotech Share Price

News

Rossari Biotech prioritises KSA project, limits India capex in FY27–FY28

Rossari Biotech projects Rs 30-50 crores FY27 pharma revenue ramp-up

Rossari Biotech targets margin improvement via portfolio optimisation and capacity utilisation

Rossari Biotech sets Q1 FY27 EBITDA margin baseline, targets 15 percent plus in 2 years

Rossari Biotech upbeat on FY28 growth outlook on improved EO availability

Rossari Biotech maintains FY27 topline growth guidance despite strong Q1 performance

Rossari Biotech flags El Nino-led challenges for agriculture segment outlook

Rossari Biotech faces uncertain revenue and profit growth outlook amid global headwinds

Rossari Biotech Q1 EBITDA rises year-on-year but margin moderates slightly

Rossari Biotech Q1 revenue rises year-on-year, strong topline momentum continues

Rossari Biotech Q1 FY26 consolidated net profit edges higher YoY

Rossari Biotech to host Q1 earnings conference call on July 20 at 5 PM

Rossari Biotech - Quaterly Results

Rossari Biotech Q4 EBITDA Rises 11% YoY to Rs 77.20 Crores, Margin at 11.28%

Rossari Biotech Q4FY26 Net Profit Rises 33.6% YoY to Rs 46 Cr, Revenue Up 20.7% to Rs 700 Cr.

Rossari Biotech reports Profit after tax of 54.73 Crores, in the March 2026 quarter

Rossari Biotech informs about disclosure

Rossari Biotech informs about updates

Rossari Biotech Outlines Priorities for Capacity Utilization, Product Portfolio, Financial Discipline in Concall.

Rossari Biotech Board Approves Greenfield Specialty Chemicals Facility in Saudi Arabia.

Rossari Biotech Ltd Share Price Today

Rossari Biotech Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator